tiprankstipranks
Voyageur Pharmaceuticals (VYYRF)
OTHER OTC:VYYRF
US Market
VYYRF
Voyageur Pharmaceuticals
RESEARCH TOOLSreports

Voyageur Pharmaceuticals (VYYRF) Financial Statements

2 Followers

Voyageur Pharmaceuticals Financial Overview

Voyageur Pharmaceuticals's market cap is currently $15.47M. The company's EPS TTM is $; its P/E ratio is -7.74; Voyageur Pharmaceuticals is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 25Feb 25Feb 24Feb 23Feb 22
Income Statement
Total RevenueC$ 11.69KC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -1.22MC$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25K
Operating IncomeC$ -3.53MC$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05M
EBITDAC$ -3.53MC$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05M
Net IncomeC$ -3.53MC$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 267.05KC$ 165.57KC$ 2.08KC$ 31.56KC$ 812.97K
Total AssetsC$ 3.11MC$ 2.60MC$ 2.16MC$ 2.10MC$ 2.57M
Total DebtC$ 40.00KC$ 40.00KC$ 40.00KC$ 25.52KC$ 42.08K
Net DebtC$ -227.05KC$ -125.57KC$ 37.91KC$ -6.04KC$ -770.89K
Total LiabilitiesC$ 1.85MC$ 2.15MC$ 727.88KC$ 630.83KC$ 660.64K
Stockholders' EquityC$ 1.25MC$ 449.96KC$ 1.44MC$ 1.46MC$ 1.91M
Cash Flow
Free Cash FlowC$ -2.89MC$ -302.29KC$ -991.25KC$ -2.00MC$ -2.09M
Operating Cash FlowC$ -2.89MC$ -302.29KC$ -991.25KC$ -1.72MC$ -1.65M
Investing Cash FlowC$ -270.02KC$ -165.96KC$ -174.72KC$ -274.15KC$ -432.08K
Financing Cash FlowC$ 3.26MC$ 631.73KC$ 1.14MC$ 1.21MC$ 2.90M
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

Income Statement >

Voyageur Pharmaceuticals Debt to Assets

Balance Sheet >

Voyageur Pharmaceuticals Cash Flow

Cash Flow >

Voyageur Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >